美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=DEXTROAMPHETAMINE SULFATE"
符合检索条件的记录共63
7 页 当前第 5 页  首页 上一页 下一页 最后一页 返回检索页
41药品名称DEXTROAMPHETAMINE SULFATE
申请号203644产品号001
活性成分DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径SOLUTION;ORAL规格5MG/5ML
治疗等效代码AA参比药物
批准日期2013/05/29申请机构TRIS PHARMA INC
42药品名称DEXTROAMPHETAMINE SULFATE
申请号203901产品号001
活性成分DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径CAPSULE, EXTENDED RELEASE;ORAL规格5MG
治疗等效代码AB参比药物
批准日期2012/11/30申请机构ACTAVIS ELIZABETH LLC
43药品名称DEXTROAMPHETAMINE SULFATE
申请号203901产品号002
活性成分DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径CAPSULE, EXTENDED RELEASE;ORAL规格10MG
治疗等效代码AB参比药物
批准日期2012/11/30申请机构ACTAVIS ELIZABETH LLC
44药品名称DEXTROAMPHETAMINE SULFATE
申请号203901产品号003
活性成分DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径CAPSULE, EXTENDED RELEASE;ORAL规格15MG
治疗等效代码AB参比药物
批准日期2012/11/30申请机构ACTAVIS ELIZABETH LLC
45药品名称DEXTROAMPHETAMINE SULFATE
申请号204330产品号001
活性成分DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径TABLET;ORAL规格5MG
治疗等效代码AA参比药物
批准日期2016/03/16申请机构NOVEL LABORATORIES INC
46药品名称DEXTROAMPHETAMINE SULFATE
申请号204330产品号002
活性成分DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径TABLET;ORAL规格10MG
治疗等效代码AA参比药物
批准日期2016/03/16申请机构NOVEL LABORATORIES INC
47药品名称DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAMINE SULFATE
申请号206159产品号001
活性成分DEXTROAMPHETAMINE SACCHARATE;AMPHETAMINE ASPARTATE MONOHYDRATE;DEXTROAMPHETAMINE SULFATE;AMPHETAMINE SULFATE市场状态暂时批准
剂型或给药途径CAPSULE, EXTENDED RELEASE;ORAL规格5MG
治疗等效代码参比药物
批准日期申请机构PAR PHARM INC
48药品名称DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAMINE SULFATE
申请号206159产品号002
活性成分DEXTROAMPHETAMINE SACCHARATE;AMPHETAMINE ASPARTATE MONOHYDRATE;DEXTROAMPHETAMINE SULFATE;AMPHETAMINE SULFATE市场状态暂时批准
剂型或给药途径CAPSULE, EXTENDED RELEASE;ORAL规格10MG
治疗等效代码参比药物
批准日期申请机构PAR PHARM INC
49药品名称DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAMINE SULFATE
申请号206159产品号003
活性成分DEXTROAMPHETAMINE SACCHARATE;AMPHETAMINE ASPARTATE MONOHYDRATE;DEXTROAMPHETAMINE SULFATE;AMPHETAMINE SULFATE市场状态暂时批准
剂型或给药途径CAPSULE, EXTENDED RELEASE;ORAL规格15MG
治疗等效代码参比药物
批准日期申请机构PAR PHARM INC
50药品名称DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAMINE SULFATE
申请号206159产品号004
活性成分DEXTROAMPHETAMINE SACCHARATE;AMPHETAMINE ASPARTATE MONOHYDRATE;DEXTROAMPHETAMINE SULFATE;AMPHETAMINE SULFATE市场状态暂时批准
剂型或给药途径CAPSULE, EXTENDED RELEASE;ORAL规格20MG
治疗等效代码参比药物
批准日期申请机构PAR PHARM INC